| Prime-boost vaccine strategy against viral infections: Mechanisms and benefits K Kardani, A Bolhassani, S Shahbazi Vaccine 34 (4), 413-423, 2016 | 240 | 2016 |
| Cell penetrating peptides: The potent multi-cargo intracellular carriers K Kardani, A Milani, S H. Shabani, A Bolhassani Expert opinion on drug delivery 16 (11), 1227-1258, 2019 | 137 | 2019 |
| An overview of in silico vaccine design against different pathogens and cancer K Kardani, A Bolhassani, A Namvar Expert Review of Vaccines, 2020 | 58 | 2020 |
| Cppsite 2.0: An available database of experimentally validated cell-penetrating peptides predicting their secondary and tertiary structures K Kardani, A Bolhassani Journal of molecular biology 433 (11), 166703, 2021 | 47 | 2021 |
| Antimicrobial/anticancer peptides: Bioactive molecules and therapeutic agents K Kardani, A Bolhassani Immunotherapy 13 (8), 669-684, 2021 | 38 | 2021 |
| Prime/boost immunization with HIV-1 MPER-V3 fusion construct enhances humoral and cellular immune responses A Bolhassani, K Kardani, R Vahabpour, N Habibzadeh, MR Aghasadeghi, ... Immunology Letters 168 (2), 366-373, 2015 | 26 | 2015 |
| Prediction of cross‐clade HIV‐1 T‐cell epitopes using immunoinformatics analysis N Khairkhah, A Namvar, K Kardani, A Bolhassani Proteins: Structure, Function, and Bioinformatics 86 (12), 1284-1293, 2018 | 24 | 2018 |
| Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches K Kardani, A Bolhassani PloS One, 2021 | 22 | 2021 |
| Comparative analysis of two HIV-1 multiepitope polypeptides for stimulation of immune responses in BALB/c mice K Kardani, A Hashemi, A Bolhassani Molecular Immunology 119, 106-122, 2020 | 17 | 2020 |
| Comparison of HIV-1 Vif and Vpu accessory proteins for delivery of polyepitope constructs harboring Nef, Gp160 and P24 using various cell penetrating peptides. K Kardani, A Hashemi, A Bolhassani PloS one 14 (10), e0223844-e0223844, 2019 | 13 | 2019 |
| In silico design and in vitro expression of novel multiepitope DNA constructs based on HIV-1 proteins and Hsp70 T-cell epitopes E Akbari, K Kardani, A Namvar, S Ajdary, EM Ardakani, V Khalaj, ... Biotechnology Letters 43 (8), 1513-1550, 2021 | 12 | 2021 |
| In Silico and in Vivo Analysis of HIV-1 Rev Regulatory Protein for Evaluation of a Multiepitope-based Vaccine Candidate SH Shabani, K Kardani, A Milani, A Bolhassani Immunological Investigations 51 (1), 1-28, 2022 | 10 | 2022 |
| Anti-viral therapy for the sexually transmitted viruses: recent updates on vaccine development K Kardani, P Basimi, M Fekri, A Bolhassani Exper Review of Clinical Pharmacology, 2020 | 10 | 2020 |
| B1 protein: a novel cell penetrating protein for in vitro and in vivo delivery of HIV-1 multi-epitope DNA constructs K Kardani, A Bolhassani, E Agi, A Hashemi Biotechnology Letters 42 (6), 2020 | 10 | 2020 |
| Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells K Kardani, J Sanchez Gil, S Rabkin Front Cell Infect Microbiol. 13 (1206111), 2023 | 8 | 2023 |
| HPV proteins and their functions K Kardani, A Bolhassani HPV Infect 1, 8, 2018 | 5 | 2018 |
| The next generation of HCV vaccines: a focus on novel adjuvant development K Kardani, SM Sadat, M Kardani, A Bolhassani Expert Review of Vaccines 20 (7), 839-855, 2021 | 4 | 2021 |
| Vaccine development against SARS-CoV-2: from virology to vaccine clinical trials K Kardani, A Bolhassani Coronaviruses, 2020 | 4 | 2020 |
| Gene delivery in adherent and suspension cells using the combined physical methods K Kardani, A Milani, A Bolhassani Cytotechnology 74 (2), 245-257, 2022 | 3 | 2022 |
| Types of benign or malignant diseases associated with HPV infections K Kardani, A Bolhassani HPV Infect Diagn Prev Treatment 30, 2018 | 3 | 2018 |
